Rafferty Asset Management
ENTA icon

Rafferty Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Rafferty Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-92,224
Closed -$1.97M – 1083
2023
Q2 		$1.97M Buy
92,224
+40,991
+80% +$1.21M 0.01% 647
2023
Q1 		$2.07M Sell
51,233
-32,181
-39% -$1.54M 0.01% 602
2022
Q4 		$3.88M Buy
83,414
+19,692
+31% +$898K 0.03% 433
2022
Q3 		$3.31M Buy
63,722
+8,526
+15% +$498K 0.04% 401
2022
Q2 		$2.61M Sell
55,196
-2,408
-4% -$131K 0.02% 414
2022
Q1 		$4.1M Buy
57,604
+9,607
+20% +$625K 0.02% 424
2021
Q4 		$3.59M Buy
47,997
+22,444
+88% +$1.76M 0.02% 496
2021
Q3 		$1.45M Buy
25,553
+1,042
+4% +$51.5K 0.01% 720
2021
Q2 		$1.08M Sell
24,511
-9,639
-28% -$472K 0.01% 859
2021
Q1 		$1.68M Buy
34,150
+25,921
+315% +$1.29M 0.01% 667
2020
Q4 		$346K Sell
8,229
-6,579
-44% -$289K ﹤0.01% 774
2020
Q3 		$678K Buy
14,808
+5,759
+64% +$279K 0.01% 637
2020
Q2 		$454K Buy
+9,049
New +$468K 0.01% 734
2020
Q1 		– Sell
-18,470
Closed -$1.14M – 664
2019
Q4 		$1.14M Sell
18,470
-22,569
-55% -$1.4M 0.02% 523
2019
Q3 		$2.47M Buy
41,039
+6,195
+18% +$460K 0.04% 285
2019
Q2 		$2.94M Buy
34,844
+250
+0.7% +$22.5K 0.05% 259
2019
Q1 		$3.3M Buy
+34,594
New +$3.1M 0.05% 200

Other funds holding ENTA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rafferty Asset Management's ENTA Position: Q3 2023 in Review

Rafferty Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q3 2023, closing a stake of 92,224 shares — an estimated $1.97M sold.

Rafferty Asset Management first reported a position in ENTA in Q1 2019 and held it in 17 quarters. The position peaked at $4.1M in Q1 2022. 132 funds tracked by Wall St. Rank hold ENTA as of Q3 2023.

  • Rafferty Asset Management reported no remaining Enanta Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 92,224 Enanta Pharmaceuticals shares in Q3 2023, an estimated $1.97M.
  • Rafferty Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2019 and held it in 17 quarters.
  • Rafferty Asset Management's Enanta Pharmaceuticals position peaked at $4.1M in Q1 2022.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2023.

Based on Rafferty Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.